These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30894497)

  • 41. Cross-talk between pro-inflammatory transcription factors and glucocorticoids.
    Adcock IM; Caramori G
    Immunol Cell Biol; 2001 Aug; 79(4):376-84. PubMed ID: 11488985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emerging corticosteroid agonists for the treatment of asthma.
    Westergaard CG; Porsbjerg C; Backer V
    Expert Opin Emerg Drugs; 2015; 20(4):653-62. PubMed ID: 26108455
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of early effects of budesonide/formoterol maintenance and reliever therapy with fluticasone furoate/vilanterol for asthma patients requiring step-up from inhaled corticosteroid monotherapy.
    Hozawa S; Terada M; Haruta Y; Hozawa M
    Pulm Pharmacol Ther; 2016 Apr; 37():15-23. PubMed ID: 26850307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin.
    Spahn JD; Leung DY; Chan MT; Szefler SJ; Gelfand EW
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):421-6. PubMed ID: 10069875
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resistance to glucocorticoids: another piece of the jigsaw.
    Ramos-Barbón D
    Arch Bronconeumol; 2011 Mar; 47(3):113-4. PubMed ID: 21396762
    [No Abstract]   [Full Text] [Related]  

  • 46. Individual variations in lymphocyte-responses to glucocorticoids in patients with bronchial asthma: comparison of potencies for five glucocorticoids.
    Hirano T; Homma M; Oka K; Tsushima H; Niitsuma T; Hayashi T
    Immunopharmacology; 1998 Jul; 40(1):57-66. PubMed ID: 9776479
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma.
    Adcock IM; Lane SJ; Brown CR; Peters MJ; Lee TH; Barnes PJ
    J Immunol; 1995 Apr; 154(7):3500-5. PubMed ID: 7897230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma.
    Goleva E; Li LB; Eves PT; Strand MJ; Martin RJ; Leung DY
    Am J Respir Crit Care Med; 2006 Mar; 173(6):607-16. PubMed ID: 16387802
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Steroid resistance in severe asthma: current mechanisms and future treatment.
    Durham A; Adcock IM; Tliba O
    Curr Pharm Des; 2011; 17(7):674-84. PubMed ID: 21406059
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mometasone furoate: an inhaled glucocorticoid for the management of asthma in adults and children.
    Cowie RL; Giembycz MA; Leigh R
    Expert Opin Pharmacother; 2009 Aug; 10(12):2009-14. PubMed ID: 19618993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glucocorticosteroids.
    Barnes PJ
    Handb Exp Pharmacol; 2017; 237():93-115. PubMed ID: 27796513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of inhaled and systemic glucocorticoid treatment on CD4
    Zuśka-Prot M; Maślanka T
    Int Immunopharmacol; 2017 Apr; 45():98-109. PubMed ID: 28189974
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanisms of glucocorticoid-resistant asthma.
    Leung DY; de Castro M; Szefler SJ; Chrousos GP
    Ann N Y Acad Sci; 1998 May; 840():735-46. PubMed ID: 9629300
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dominance of the strongest: inflammatory cytokines versus glucocorticoids.
    Dejager L; Vandevyver S; Petta I; Libert C
    Cytokine Growth Factor Rev; 2014 Feb; 25(1):21-33. PubMed ID: 24412262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors influencing the responsiveness to inhaled glucocorticoids of patients with moderate-to-severe asthma.
    Jang AS; Lee JH; Park SW; Lee YM; Uh ST; Kim YH; Park CS
    Chest; 2005 Sep; 128(3):1140-5. PubMed ID: 16162699
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neutrophil extracellular traps are downregulated by glucocorticosteroids in lungs in an equine model of asthma.
    Vargas A; Boivin R; Cano P; Murcia Y; Bazin I; Lavoie JP
    Respir Res; 2017 Dec; 18(1):207. PubMed ID: 29233147
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cysteine oxidation impairs systemic glucocorticoid responsiveness in children with difficult-to-treat asthma.
    Stephenson ST; Brown LA; Helms MN; Qu H; Brown SD; Brown MR; Fitzpatrick AM
    J Allergy Clin Immunol; 2015 Aug; 136(2):454-61.e9. PubMed ID: 25748343
    [TBL] [Abstract][Full Text] [Related]  

  • 58. p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma.
    Irusen E; Matthews JG; Takahashi A; Barnes PJ; Chung KF; Adcock IM
    J Allergy Clin Immunol; 2002 Apr; 109(4):649-57. PubMed ID: 11941315
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A dissociated glucocorticoid receptor modulator reduces airway hyperresponsiveness and inflammation in a mouse model of asthma.
    Reber LL; Daubeuf F; Plantinga M; De Cauwer L; Gerlo S; Waelput W; Van Calenbergh S; Tavernier J; Haegeman G; Lambrecht BN; Frossard N; De Bosscher K
    J Immunol; 2012 Apr; 188(7):3478-87. PubMed ID: 22393156
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Steroid-insensitive ERK1/2 activity drives CXCL8 synthesis and neutrophilia by airway smooth muscle.
    Robins S; Roussel L; Schachter A; Risse PA; Mogas AK; Olivenstein R; Martin JG; Hamid Q; Rousseau S
    Am J Respir Cell Mol Biol; 2011 Nov; 45(5):984-90. PubMed ID: 21493783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.